TRNS Form 4: Cynthia Langston Acquires RSUs; Option Granted at $73.80
Rhea-AI Filing Summary
Transcat, Inc. (TRNS) reporting person Cynthia Langston, a director, recorded equity award activity on Form 4. On 09/11/2025 Ms. Langston was reported to have acquired 704 shares through vesting or conversion of restricted stock units at $0 per share and continues to beneficially own 1,837 shares of common stock directly after the reported transactions. A prior grant of 1,587 RSUs (granted 09/10/2025) was noted as exempt under Rule 16b-3 and generally vests on 09/10/2026, while 1,587 RSUs vested on 09/10/2025 and converted one-for-one into common shares. Additionally, a stock option covering 10,000 shares with an exercise price of $73.80 and a five-year pro rata vesting schedule was reported.
Positive
- Director equity alignment: Vesting of RSUs converted to 704 shares on 09/11/2025, increasing direct ownership to 1,837 shares
- Clear disclosure: Grants and vesting schedules provided, including a 10,000-share option at $73.80 with pro rata five-year vesting
Negative
- None.
Insights
TL;DR: Director received vested RSUs and an option grant; these are routine compensation events with limited immediate market impact.
The Form 4 discloses an insider compensation-related increase in direct holdings via RSU vesting and a standard time-vested stock option covering 10,000 shares at $73.80. The 704-share acquisition on 09/11/2025 was through RSU conversion at no cash price, increasing direct beneficial ownership to 1,837 shares. The separate 1,587-RSU grant is subject to a one-year vesting cliff to 09/10/2026. From a capital-markets perspective, these are governance/compensation items rather than transactional signals about company operations; absent material size context versus outstanding shares, market impact is likely neutral.
TL;DR: Report shows standard director compensation through RSUs and an option with staged vesting; disclosure aligns with Rule 16 reporting expectations.
The filing clearly indicates awards granted under an exempt Rule 16b-3 transaction and subsequent vesting events. The separate RSU grants and the 10,000-share option with five-year pro rata vesting reflect common long-term alignment practices for directors. The Form 4 is complete regarding transaction dates, amounts, and exercise price, and was signed by an attorney-in-fact, which is typical for officer/director filings.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 704 | $0.00 | -- |
| Exercise | Common Stock, $.50 par value | 704 | $0.00 | -- |
| Grant/Award | These restricted stock units ( | 1,587 | $0.00 | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
Footnotes (1)
- These restricted stock units ("RSUs") convert into common stock on a one-for-one basis. These RSUs were granted in a transaction exempt under Rule 16b-3 and, except as otherwise provided in the award agreement, vest on September 10, 2026. These RSUs vested on September 11, 2025. This option vests and becomes exercisable pro rata with respect to one-fifth of the shares subject to the option on the first, second, third, fourth and fifth anniversaries of the date of grant, except as otherwise provided in the award agreement.
